Invitrogen IVGN | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Invitrogen IVGN

An SI Board Since January 1999

Posts	SubjectMarks	Bans
73	6	0

Emcee: Doug DuBois	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
48	i generally like the stock below $60, i am a little concerned piper is too optim	mopgcw	-	7/16/2006
47	Here's a 6th reason to own IVGN: biz.yahoo.com If you look closely, you	tuck	-	7/15/2006
46	Piper Jaffray & Co. Company Note June 19, 2006 Invitrogen Corporation	mopgcw	-	7/12/2006
45	Invitrogen Licenses Geron Intellectual Property for Development of Research Tool	mopgcw	-	6/30/2006
44	Affymetrix and Invitrogen Enter Into Licensing Agreement Wednesday June 21, 8:00	mopgcw	-	6/21/2006
43	Invitrogen Announces First Quarter 2006 Results Thursday April 27, 4:05 pm ET	mopgcw	-	4/30/2006
42	Management Buy-out of BioReliance Heidelberg Announced Thursday April 27, 2:00 a	mopgcw	-	4/27/2006
41	forbes: Invitrogen Shares Look Range Bound Peter Kang, 04.19.06, 10:38 AM ET B	mopgcw	-	4/22/2006
40	Invitrogen Announces Preliminary First Quarter Results Monday April 17, 8:00 am	mopgcw	-	4/17/2006
39	smartmoney: Picks and Shovels By Mark Glassman Published: April 3, 2006 NO	mopgcw	-	4/14/2006
38	Invitrogen Presents Depth of Innovations at BIO 2006 Conference Friday April 7,	mopgcw	-	4/14/2006
37	Invitrogen Corporation Taps Renowned Stem Cell Expert Mahendra Rao, MD, Ph.D. to	mopgcw	-	4/14/2006
36	Invitrogen and Signalomics Collaborate to Develop Nanotechnology-Based Approache	mopgcw	-	4/14/2006
35	Invitrogen Up on Earns, Upgrade, Deal Wednesday March 1, 1:38 pm ET Invitrogen S	richardred	-	3/1/2006
34	New England Biolabs Leads Restriction Enzyme Market ARLINGTON, Va., Feb. 23 /PR	richardred	-	2/24/2006
33	piper KEY POINTS: 12/15/05 * Invitrogen announced this morning the acquisition	mopgcw	-	2/1/2006
32	Xcyte Therapies and Invitrogen Announce Signing of Asset Purchase Agreement Thur	mopgcw	-	12/16/2005
31	UPDATE 1-Invitrogen projects 2005, 2006 earnings per share Wed Dec 14, 2005 09:0	mopgcw	-	12/16/2005
30	Invitrogen Enters into Worldwide Co-Marketing Agreement with genOway Focused on	mopgcw	-	12/16/2005
29	Strategic "realignment" (as opposed to a restructuring which would imp	tuck	-	12/6/2005
28	17-Nov-05 6:11 PM Hoffmeister David F Chief Financial Officer 1,530 Market Purc	mopgcw	-	12/4/2005
27	Invitrogen, Procter & Gamble Extend Research Agreement; Successful RNAi Rese	mopgcw	-	11/2/2005
26	Invitrogen Announces Third Quarter 2005 Results Thursday October 27, 4:05 pm ET	mopgcw	-	10/31/2005
25	Health Stocks in Motion By Mark Martinez TheStreet.com Staff Reporter 10/28/2	mopgcw	-	10/31/2005
24	Invitrogen and the National Center for Drug Screening (Shanghai) Announce Collab	mopgcw	-	10/31/2005

Go to reply# or date (mm/dd/yy):